These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 28367758)

  • 1. Bortezomib as a Novel Approach to Early Recurrent Membranous Glomerulonephritis After Kidney Transplant Refractory to Combined Conventional Rituximab Therapy.
    Barbari A; Chehadi R; Kfoury Assouf H; Kamel G; Jaafar M; Abdallah A; Rizk S; Masri M
    Exp Clin Transplant; 2017 Jun; 15(3):350-354. PubMed ID: 28367758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipase A2 receptor positive membranous nephropathy long after living donor kidney transplantation between identical twins.
    Saito H; Hamasaki Y; Tojo A; Shintani Y; Shimizu A; Nangaku M
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():101-4. PubMed ID: 26031599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre- and Posttransplant Refractory Idiopathic Membranous Glomerulonephritis: The Forgotten Potential Culprit.
    Barbari A
    Exp Clin Transplant; 2017 Oct; 15(5):483-489. PubMed ID: 28847264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complete biopsy-proven resolution of deposits in recurrent proliferative glomerulonephritis with monoclonal IgG deposits (PGNMIGD) following rituximab treatment in renal allograft.
    Von Visger J; Cassol C; Nori U; Franco-Ahumada G; Nadasdy T; Satoskar AA
    BMC Nephrol; 2019 Feb; 20(1):53. PubMed ID: 30764798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of allogeneic hematopoietic stem cell transplantation-related membranous glomerulonephritis.
    Hiramatsu R; Ubara Y; Sawa N; Hasegawa E; Kawada M; Imafuku A; Sumida K; Mise K; Yamanouchi M; Ueno T; Sekine A; Hayami N; Suwabe T; Hoshino J; Takaichi K; Ohashi K; Fujii T; Wake A; Taniguchi S
    Hum Pathol; 2016 Apr; 50():187-94. PubMed ID: 26997455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Membranous nephropathy with light chain restricted deposits.
    Ramachandran R; Inamdar N; Bharati J; Yadav AK; Kumar A; Prakash G; Nada R; Rathi M; Kohli HS; Gupta KL; Jha V
    Nephrology (Carlton); 2018 Aug; 23(8):791-796. PubMed ID: 29633425
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent Membranous Nephropathy After Kidney Transplantation Associated With Phospholipase A2 Receptor and Successfully Treated With Rituximab: A Case Report.
    Ishiwatari A; Wakai S; Shirakawa H; Honda K
    Transplant Proc; 2018 Oct; 50(8):2565-2568. PubMed ID: 30316399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence of anti-neutrophil cytoplasmic antibody vasculitis in the kidney allograft.
    Lau D; Summers S; Amos L; Simpson I; Mulley W
    Nephrology (Carlton); 2012 Apr; 17 Suppl 1():16-9. PubMed ID: 22497649
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Treatment of idiopathic membranous nephropathy. Is the anti-CD20 antibody rituximab a reasonable option?].
    Busch M; Gerth J; Ott U; Schip A; Haufe CC; Gröne HJ; Wolf G
    Med Klin (Munich); 2008 Jul; 103(7):519-24. PubMed ID: 18604487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of acute antibody-mediated rejection using bortezomib: a case report.
    Sin YH; Kim YJ; Oh JS; Lee JH; Kim SM; Kim JK
    Nephrology (Carlton); 2015 Jul; 20 Suppl 2():86-9. PubMed ID: 26031595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy.
    Teisseyre M; Cremoni M; Boyer-Suavet S; Crepin T; Benzaken S; Zorzi K; Esnault V; Brglez V; Seitz-Polski B
    Front Immunol; 2021; 12():738788. PubMed ID: 34721403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Efficiency of rituximab treatment for recurrence of membranous glomerulopathy after renal transplantation].
    Wéclawiak H; Ribes D; Modesto A; Kamar N; Durand D; Rostaing L
    Nephrol Ther; 2007 Apr; 3(2):65-8. PubMed ID: 17452303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rituximab Administered for Recurrent Membranous Nephropathy in a Kidney Transplant Recipient Did Not Eliminate Donor-Specific Antibodies.
    Giannopoulou M; Tarassi K; Tsouka G; Christodoulidou C; Stefanidis I; Eleftheriadis T
    Exp Clin Transplant; 2022 Jul; 20(7):695-697. PubMed ID: 35924746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Membranous Nephropathy after MENTOR.
    Trivin-Avillach C; Beck LH
    Clin J Am Soc Nephrol; 2020 Mar; 15(3):415-417. PubMed ID: 31740571
    [No Abstract]   [Full Text] [Related]  

  • 15. Recurrent Proliferative Glomerulonephritis With Monoclonal Immunoglobulin Deposits in Kidney Allografts Treated With Anti-CD20 Antibodies.
    Buxeda A; Said SM; Nasr SH; Leung N; El Ters M; Cosio FG
    Transplantation; 2019 Jul; 103(7):1477-1485. PubMed ID: 30747850
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial effect of rituximab in the treatment of recurrent idiopathic membranous nephropathy after kidney transplantation.
    Sprangers B; Lefkowitz GI; Cohen SD; Stokes MB; Valeri A; Appel GB; Kunis CL
    Clin J Am Soc Nephrol; 2010 May; 5(5):790-7. PubMed ID: 20185599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent idiopathic membranous glomerulonephritis after kidney transplantation and successful treatment with rituximab.
    Makhdoomi K; Abkhiz S; Noroozinia F; Mivefroshan A; Zeinali J; Jafari L; Jafari L; Saffarifard A
    Iran J Kidney Dis; 2015 Mar; 9(2):158-62. PubMed ID: 25851296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
    Fervenza FC; Appel GB; Barbour SJ; Rovin BH; Lafayette RA; Aslam N; Jefferson JA; Gipson PE; Rizk DV; Sedor JR; Simon JF; McCarthy ET; Brenchley P; Sethi S; Avila-Casado C; Beanlands H; Lieske JC; Philibert D; Li T; Thomas LF; Green DF; Juncos LA; Beara-Lasic L; Blumenthal SS; Sussman AN; Erickson SB; Hladunewich M; Canetta PA; Hebert LA; Leung N; Radhakrishnan J; Reich HN; Parikh SV; Gipson DS; Lee DK; da Costa BR; Jüni P; Cattran DC;
    N Engl J Med; 2019 Jul; 381(1):36-46. PubMed ID: 31269364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Multicenter Randomized Controlled Trial of Rituximab versus Cyclosporine in the Treatment of Idiopathic Membranous Nephropathy (MENTOR).
    Fervenza FC; Canetta PA; Barbour SJ; Lafayette RA; Rovin BH; Aslam N; Hladunewich MA; Irazabal MV; Sethi S; Gipson DS; Reich HN; Brenchley P; Kretzler M; Radhakrishnan J; Hebert LA; Gipson PE; Thomas LF; McCarthy ET; Appel GB; Jefferson JA; Eirin A; Lieske JC; Hogan MC; Greene EL; Dillon JJ; Leung N; Sedor JR; Rizk DV; Blumenthal SS; Lasic LB; Juncos LA; Green DF; Simon J; Sussman AN; Philibert D; Cattran DC;
    Nephron; 2015; 130(3):159-68. PubMed ID: 26087670
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathology and clinical features of early recurrent membranous glomerulonephritis.
    Rodriguez EF; Cosio FG; Nasr SH; Sethi S; Fidler ME; Stegall MD; Grande JP; Fervenza FC; Cornell LD
    Am J Transplant; 2012 Apr; 12(4):1029-38. PubMed ID: 22233329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.